Hsiao, Yu-YuYu-YuHsiaoYI-CHIA HUANGSUI-YUAN CHANGCHING-HUA KUOChang, Shu-FangShu-FangChangLin, Ya-TingYa-TingLinLuo, Yu-ZhenYu-ZhenLuoLee, Yu-LinYu-LinLeeCHIEN-CHING HUNG2021-03-172021-03-172021-02-0616841182https://scholars.lib.ntu.edu.tw/handle/123456789/553008Combination antiretroviral therapy; HIV infection; Nucleic-acid amplification test; Resistance-associated mutation[SDGs]SDG3cobicistat plus elvitegravir plus emtricitabine plus tenofovir alafenamide; darunavir; emtricitabine; lamivudine; tenofovir disoproxil; virus RNA; anti human immunodeficiency virus agent; emtricitabine; tenofovir; adult; antiretroviral therapy; antiviral resistance; case report; clinical article; gene mutation; human; Human immunodeficiency virus infection; Letter; male; medication compliance; patient compliance; pre-exposure prophylaxis; sustained virologic response; combination drug therapy; drug effect; genetics; Human immunodeficiency virus; Human immunodeficiency virus infection; multidrug resistance; mutation; pre-exposure prophylaxis; procedures; Adult; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Emtricitabine; HIV; HIV Infections; Humans; Male; Mutation; Pre-Exposure Prophylaxis; TenofovirFailure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistanceletter10.1016/j.jmii.2021.01.011335970752-s2.0-85101700628https://scholars.lib.ntu.edu.tw/handle/123456789/552573